356 related articles for article (PubMed ID: 12117305)
1. Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets.
Verspohl EJ; Johannwille B; Waheed A; Neye H
Can J Physiol Pharmacol; 2002 Jun; 80(6):562-8. PubMed ID: 12117305
[TBL] [Abstract][Full Text] [Related]
2. Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell.
Petit P; Hillaire-Buys D; Manteghetti M; Debrus S; Chapal J; Loubatières-Mariani MM
Br J Pharmacol; 1998 Nov; 125(6):1368-74. PubMed ID: 9863669
[TBL] [Abstract][Full Text] [Related]
3. Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated microglia via P2y receptors.
Ogata T; Chuai M; Morino T; Yamamoto H; Nakamura Y; Schubert P
Brain Res; 2003 Aug; 981(1-2):174-83. PubMed ID: 12885439
[TBL] [Abstract][Full Text] [Related]
4. P2 receptor agonists stimulate insulin release from human pancreatic islets.
Fernandez-Alvarez J; Hillaire-Buys D; Loubatières-Mariani MM; Gomis R; Petit P
Pancreas; 2001 Jan; 22(1):69-71. PubMed ID: 11138974
[TBL] [Abstract][Full Text] [Related]
5. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
Ho C; Hicks J; Salter MW
Br J Pharmacol; 1995 Dec; 116(7):2909-18. PubMed ID: 8680724
[TBL] [Abstract][Full Text] [Related]
6. Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype.
Santini E; Cuccato S; Madec S; Chimenti D; Ferrannini E; Solini A
Endocrinology; 2009 Jun; 150(6):2596-602. PubMed ID: 19196799
[TBL] [Abstract][Full Text] [Related]
7. Involvement of P2X receptors in the regulation of insulin secretion, proliferation and survival in mouse pancreatic β-cells.
Ohtani M; Ohura K; Oka T
Cell Physiol Biochem; 2011; 28(2):355-66. PubMed ID: 21865744
[TBL] [Abstract][Full Text] [Related]
8. Characterization by antagonists of P2-receptors mediating endothelium-dependent relaxation in the rat aorta.
Hansmann G; Bültmann R; Tuluc F; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):641-52. PubMed ID: 9402045
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the existence of P2Y1,2,4 receptor subtypes in HEK-293 cells: reactivation of P2Y1 receptors after repetitive agonist application.
Fischer W; Franke H; Gröger-Arndt H; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):466-72. PubMed ID: 16025270
[TBL] [Abstract][Full Text] [Related]
10. P2-purinoceptors mediating spasm of the isolated uterus of the non-pregnant guinea-pig.
Piper AS; Hollingsworth M
Br J Pharmacol; 1996 Apr; 117(8):1721-9. PubMed ID: 8732282
[TBL] [Abstract][Full Text] [Related]
11. Responses of the longitudinal muscle and the muscularis mucosae of the rat duodenum to adenine and uracil nucleotides.
Johnson CR; Charlton SJ; Hourani SM
Br J Pharmacol; 1996 Mar; 117(5):823-30. PubMed ID: 8851497
[TBL] [Abstract][Full Text] [Related]
12. Contractile effects of uridine 5'-triphosphate in the rat duodenum.
Johnson CR; Hourani SM
Br J Pharmacol; 1994 Dec; 113(4):1191-6. PubMed ID: 7889272
[TBL] [Abstract][Full Text] [Related]
13. P2Y receptor activation enhances insulin release from pancreatic beta-cells by triggering the cyclic AMP/protein kinase A pathway.
Chevassus H; Roig A; Belloc C; Lajoix AD; Broca C; Manteghetti M; Petit P
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):464-9. PubMed ID: 12382076
[TBL] [Abstract][Full Text] [Related]
14. Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.
Rodrigues RJ; Almeida T; Richardson PJ; Oliveira CR; Cunha RA
J Neurosci; 2005 Jul; 25(27):6286-95. PubMed ID: 16000618
[TBL] [Abstract][Full Text] [Related]
15. Characterization of P2X3, P2Y1 and P2Y4 receptors in cultured HEK293-hP2X3 cells and their inhibition by ethanol and trichloroethanol.
Fischer W; Wirkner K; Weber M; Eberts C; Köles L; Reinhardt R; Franke H; Allgaier C; Gillen C; Illes P
J Neurochem; 2003 May; 85(3):779-90. PubMed ID: 12694404
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.
Bailey SJ; Hourani SM
Br J Pharmacol; 1994 May; 112(1):219-25. PubMed ID: 8032645
[TBL] [Abstract][Full Text] [Related]
17. Relative contribution of P2U- and P2Y-purinoceptors to endothelium-dependent vasodilatation in the golden hamster isolated mesenteric arterial bed.
Ralevic V; Burnstock G
Br J Pharmacol; 1996 Apr; 117(8):1797-802. PubMed ID: 8732294
[TBL] [Abstract][Full Text] [Related]
18. P2Y and P2U receptors differentially release intracellular Ca2+ via the phospholipase c/inositol 1,4,5-triphosphate pathway in astrocytes from the dorsal spinal cord.
Idestrup CP; Salter MW
Neuroscience; 1998 Oct; 86(3):913-23. PubMed ID: 9692727
[TBL] [Abstract][Full Text] [Related]
19. P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
von Kügelgen I; Stoffel D; Starke K
Br J Pharmacol; 1995 May; 115(2):247-54. PubMed ID: 7670726
[TBL] [Abstract][Full Text] [Related]
20. P2-receptor-mediated inhibition of noradrenaline release in the rat hippocampus.
Koch H; von Kügelgen I; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):707-15. PubMed ID: 9205954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]